It has been a little quiet on the broker note front this week due to the imminent Christmas break.
In light of this, I thought I would pick out three recent broker buy recommendations that have stood out this month.
Here’s why leading brokers think investors should be buying these ASX shares:
Afterpay Limited (ASX: APT)
Analysts at Goldman Sachs have retained their conviction buy rating and $42.90 price target on this payments company’s shares. The broker was pleased with After[ay’s performance in November and during the Black Friday and Cyber Monday sales events. Afterpay reported a 160% increase in underlying sales in November and revealed that it has now surpassed 3 million customers in the United States and 500,000 in the United Kingdom. This lifted total customer numbers to 6.6 million. I agree with Goldman Sachs on Afterpay and feel it could be a great buy and hold option for investors with a higher tolerance for risk.
CSL Limited (ASX: CSL)
According to another note out of Goldman Sachs, its analysts have retained their buy rating and lifted the price target on this biotherapeutics giant’s shares to $312. Goldman increased its price target after running the rule over its R&D pipeline. After assessing the data and likely regulatory pathway, the broker calculates a total risk-adjusted valuation of $38 per share is in its near term pipeline. I also agree with Goldman Sachs on CSL and believe it would be another great long-term option. This is due to the aforementioned pipeline and the strong demand it is experiencing for its existing products.
Xero Limited (ASX: XRO)
A note out of Morgan Stanley reveals that its analysts have retained their overweight rating and lifted the price target on this accounting software provider’s shares to $90. Morgan Stanley looks to have been impressed with Xero’s first half result and particularly its margin expansion. It also notes that Xero’s international contribution margins are breaking even for the first time. Overall, the broker forecasts strong sales growth in FY 2020 and appears confident this can continue in the near term. I think Morgan Stanley is on the money with this one and agree that it is a buy.
The post Leading brokers name 3 ASX shares to buy appeared first on Motley Fool Australia.
And here are more ASX shares that have recently been given buy ratings.
Our Motley Fool experts have just released a brand new FREE report, detailing 5 dirt cheap shares that you can buy today.
One stock is an Australian internet darling with a rock solid reputation and an exciting new business line that promises years (or even decades) of growth… while trading at an ultra-low price…
Another is a diversified conglomerate trading near a 52-week low all while offering a 2.8% fully franked yield...
Plus 3 more cheap bets that could position you to profit over the next 12 months!
See for yourself now. Simply click the link below to scoop up your FREE copy and discover all 5 shares. But you will want to hurry – this free report is available for a brief time only.
- Man bets $221,666 on one ASX stock
- Top analysts name their top 3 ASX blue chip shares for 2019
- 3 quality dividend shares to boost your income
- NEW: Free report names top 3 ASX dividend shares to buy for 2019
- 5 Stocks for Potentially Building Wealth After 50
James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of AFTERPAY T FPO and CSL Ltd. The Motley Fool Australia owns shares of Xero. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The Motley Fool's purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool's free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson. 2019